SAM
IRMD icon

Sawgrass Asset Management’s iRadimed IRMD Stock Holding History

Sawgrass Asset Management’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$272K Buy
2,826
+112
+4% +$11.2K 0.04% 156
2025
Q4 		$264K Buy
+2,714
New +$233K 0.03% 159
2022
Q2 		– Sell
-6,102
Closed -$274K – 159
2022
Q1 		$274K Buy
+6,102
New +$282K 0.03% 147

Other funds holding IRMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sawgrass Asset Management's IRMD Position: Q1 2026 in Review

Sawgrass Asset Management increased its iRadimed (IRMD) stake by 4.1% in Q1 2026, buying an estimated $11.2K and bringing the position to 2,826 shares worth $272K. The position accounts for 0.04% of the portfolio, ranked #156.

Sawgrass Asset Management first reported a position in IRMD in Q1 2022 and has held it in 3 quarters since. The position peaked at $274K in Q1 2022. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

  • Sawgrass Asset Management held 2,826 shares of iRadimed worth $272K as of Q1 2026.
  • Sawgrass Asset Management bought 112 iRadimed shares in Q1 2026, an estimated $11.2K.
  • iRadimed made up 0.04% of Sawgrass Asset Management's portfolio in Q1 2026, its #156 holding.
  • Sawgrass Asset Management first reported a position in iRadimed in Q1 2022 and has held it in 3 quarters since.
  • Sawgrass Asset Management's iRadimed position peaked at $274K in Q1 2022.
  • 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on Sawgrass Asset Management's 13F filing for Q1 2026, filed 1 May 2026.